China

Podcast

How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai

9 February 2026

Content

AstraZeneca Plans $15B China Investment Through 2030

29 January 2026

Expert Insight

China’s Biotech Ascent Reshapes Global Pharma Strategy, Dominates JPM26 Discussions

19 January 2026

Manufacturing

Trend Briefing: “China-Proofing” the Pharma Supply Chain

3 September 2023

Podcast

How Cognition Therapeutics Cut Cost of Goods by 85% Through Smarter CMC Strategy

9 July 2020

Expert Insight

Radioligand Therapy: How China Is Shaping the Future of CDMO Infrastructure

27 March 2020